Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 348

The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.

Use of prenatal chromosomal microarray: prospective cohort study and systematic review and meta-analysis: Prenatal CMA: cohort study and systematic review

Open access
Hillman, S. C., McMullan, D. J., Hall, G., Togneri, F. S., James, N., Maher, E. J., Meller, C. H., Williams, D., Wapner, R. J., Maher, E. R., Kilby, M. D.·2013·Ultrasound in Obstetrics & Gynecology

Abstract

OBJECTIVES: Chromosomal microarray analysis (CMA) is utilized in prenatal diagnosis to detect chromosomal abnormalities not visible by conventional karyotyping. A prospective cohort of women undergoing fetal CMA and karyotyping following abnormal prenatal ultrasound findings is presented in the context of a systematic review and meta-analysis of the literature describing detection rates by CMA and karyotyping. METHODS: We performed a prospective cohort study of 243 women undergoing CMA alongside karyotyping when a structural abnormality was detected on prenatal ultrasound. A systematic review of the literature was also performed. MEDLINE (1970-Dec 2012), EMBASE (1980-Dec 2012) and CINAHL (1982-June 2012) databases were searched electronically. Selected studies included > 10 cases and prenatal CMA in addition to karyotyping. The search yielded 560 citations. Full papers were retrieved for 86, and 25 primary studies were included in the systematic review. RESULTS: Our cohort study found an excess detection rate of abnormalities by CMA of 4.1% over conventional karyotyping when the clinical indication for testing was an abnormal fetal ultrasound finding; this was lower than the detection rate of 10% (95% CI, 8-13%) by meta-analysis. The rate of detection for variants of unknown significance (VOUS) was 2.1% (95% CI, 1.3-3.3%) when the indication for CMA was an abnormal scan finding. The VOUS detection rate was lower (1.4%; 95% CI, 0.5-3.7%) when any indication for prenatal CMA was meta-analyzed. CONCLUSION: We present evidence for a higher detection rate by CMA than by karyotyping not just in the case of abnormal ultrasound findings but also in cases of other indications for invasive testing. It is likely that CMA will replace karyotyping in high-risk pregnancies.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/uog.12464

Cites

32 of 32 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 32 references

Cited by

See all 348

Metadata

Authors
Hillman, S. C., McMullan, D. J., Hall, G., Togneri, F. S., James, N., Maher, E. J., Meller, C. H., Williams, D., Wapner, R. J., Maher, E. R., & Kilby, M. D.
Venue
Ultrasound in Obstetrics & Gynecology
Publisher
Wiley
Published
2013-05-07
Volume
41
Issue
6
Pages
610-620
ISSN
0960-7692 (ISSN-L)
OpenAlex
W1552325500
Cited by
348
References
32
FWCI
3.83
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Use of prenatal chromosomal microarray: prospective cohort study and systematic review and meta-analysis: Prenatal CMA: cohort study and systematic review. https://app.cochat.ai/papers/10.1002/uog.12464
The paper
Hillman, S. C., McMullan, D. J., Hall, G., Togneri, F. S., James, N., Maher, E. J., Meller, C. H., Williams, D., Wapner, R. J., Maher, E. R., & Kilby, M. D. (2013). Use of prenatal chromosomal microarray: prospective cohort study and systematic review and meta-analysis: Prenatal CMA: cohort study and systematic review. Ultrasound in Obstetrics & Gynecology. https://doi.org/10.1002/uog.12464

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.